AHA Coding Clinic® for HCPCS - 2013 Issue 3; Ask the Editor
Zoledronic acid (Reclast®)
The coders at our facility are concerned about the correct reporting of Zoledronic acid (Reclast®). This drug is packaged in a bottle/vial for intravenous infusion. One bottle/vial contains 5 mg of the Zoledronic acid solution. A normal dose of Zoledronic acid is 5 mg, which should only be administered once every 12 months. The dilemma is that according to the Centers for Medicare & Medicaid Services (CMS) drugs should not be reported based on how the drug is packaged, stored, or stocked. So, if a patient receives 5 mg of Zoledronic acid, how would this be correctly reported when the HCPCS code descriptor states Q2051, Injection, zoledronic acid, not otherwise specified, 1 mg? ...
To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.
Thank you for choosing Find-A-Code, please Sign In to remove ads.